Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

20 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

E.E.S. Articles

Genes linked to MS severity

17 December 2007

Eisai launches new Aricept formulation in UK

29 January 2007

Japan stock market week to May 30

6 June 2005

Akzo's Diosynth signs deal with Human Genome Sciences

21 June 2004

Procter & Gamble Pharma buys Spanish drugmaker Grupo Vita

8 March 2004

Grupo Vita denies approach from P&G

1 March 2004

Grupo Vita and H-Pharm sign agreement for Eneas

20 October 2003

Fournier to sell Eneas in Turkey

2 June 2003

Grupo Vito launches Eneas in Spain for hypertension treatment

17 June 2002

Spain's Grupo Vita gains ENEAS appro

11 February 2002

Akzo Nobel predicts double-digit pharma growth for 2001

10 October 2001

Akzo expanding Diosynth site

5 October 2001

Further biotech acquisition for Akzo Nobel

24 April 2001

Akzo Nobel To Invest In New Pharma Plant

9 July 1998

Showing 1-14 of 14 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Australia's pharma industry applauds R&D regulatory reform
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Australia's pharma industry applauds R&D regulatory reform

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS